All News Avacta Group Plc

Equities

Delayed London S.E. Other stock markets 08:55:11 2024-06-18 EDT			5-day change	1st Jan Change
40.7 ^GBX	+2.39%		-0.12%	-65.06%

05-23	Windward wins deal; Kodal progresses at Bougouni	AN
05-23	Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial	CI

Avacta Group plc - Appointment of Nominated Adviser and Sole Broker	06-12	AQ
Avacta : Targeting the Tumor Microenvironment – June 2024 presentation deck	06-03	PU
Avacta : Annual Report and Accounts 2023	05-31	PU
Avacta : AGM Notice – 2024	05-31	PU
Windward wins deal; Kodal progresses at Bougouni	05-23	AN
Avacta Group plc Announces Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta's Ava6000 Phase 1 Trial	05-23	CI
AstraZeneca target raised; Antofagasta lowered	05-07	AN
Avacta Group plc - Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	05-01	AQ
Avacta picks Christina Coughlin to replace long-serving CEO	05-01	AN
EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down	04-30	AN
Avacta Group CEO Steps Down; Successor Appointed	04-30	MT
Transcript : Avacta Group Plc, 2023 Earnings Call, Apr 30, 2024	04-30
Avacta : Results for the Year Ended 31 December 2023	04-30	PU
Avacta : Preliminary Results for the Year Ended 31 December 2023	04-30	PU
Avacta : Christina Coughlin, MD, PhD, appointed Chief Executive Officer of Avacta Group	04-30	PU
Avacta Group Plc Reports Earnings Results for the Full Year Ended December 31, 2023	04-30	CI
Avacta Group plc Announces Chief Executive Officer Changes	04-30	CI
Avacta : R&D Spotlight series – Episode 2	04-25	PU
Avacta Group plc - Block Listing Application to AIM	04-24	AQ
Avacta Group plc - Notice of Results	04-24	AQ

No results for this search